The list of the second batch of production and education integration enterprises in the province was announced, and Lunan Pharmaceutical Group was selected

On April 11, the Shandong Provincial Development and Reform Commission Office issued the “Notice on Printing and Distributing the List of Shandong Province’s Industry-Education Integration Pilot Cities and the Second Batch of Industry-Education Integration Enterprises Construction and Cultivation Inventory List”, Lunan Pharmaceutical Group Co., Ltd. Co., Ltd. was selected into the second batch of production and education integration enterprise construction and cultivation storage list in Shandong Province.

In recent years, Lunan Pharmaceutical has gradually explored and formed a new school-enterprise cooperation talent training model featuring industry-education integration, industry-university cooperation, and collaborative education, and the introduction of talents has continued to grow. Up to now, Lunan Pharmaceutical has established technical and talent cooperation with more than 100 universities and research institutes including Shandong University, East China University of Science and Technology, Shenyang Pharmaceutical University, Lanzhou University, Nanjing Medical University, etc. Co-established Lunan Pharmaceutical School-Enterprise Cooperation Class with 4 universities including Jinan University, co-established Lunan Pharmaceutical Industry College with Linyi University and other two colleges and universities, and co-established Lunan Pharmaceutical Order Class with more than ten colleges and universities, with nearly 1,000 students enrolled people.

Under the collaborative innovation system combining “production, learning, research and application”, Lunan Pharmaceutical has cultivated and created a scientific research team with more than 60 doctors and more than 1,700 masters, and more A number of candidates for the National Hundred Thousand Talents Project, experts with special government allowances from the State Council, Taishan Scholars, and Taishan Industry Leading Talents.

The company has also established a national enterprise technology center, a post-doctoral research station, a state key laboratory for generic technology in traditional Chinese medicine, a national chiral pharmaceutical engineering technology research center, and a national engineering laboratory for mammalian cell high-efficiency expression. 5 There are 8 national scientific research platforms and 8 provincial scientific research platforms, covering three categories of chemical drugs, traditional Chinese medicines and biological drugs, and can conduct research and development of more than 100 varieties of new drugs at the same time.

Qilu Evening News Qilu One Point Correspondent Liu Juan